Frequent occurrence of RASSF1A promoter hypermethylation and Merkel cell polyomavirus in Merkel cell carcinoma

Molecular Carcinogenesis

Volumn 48, Issue 10, 2009, Pages 903-909

  Helmbold, Peter ^a   Lahtz, Christoph ^b   Enk, Alexander ^a   Herrmann Trost, Peter ^c   Marsch, Wolfgang Ch ^d   Kutzner, Heinz ^e   Dammann, Reinhard H ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c Institute of Pathology   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e Dermatopathologische Gemeinschaftspraxis   (Germany)

Author keywords

DNA methylation; Epigenetics; Skin cancer; Tumor suppressor gene; Virus infection

Indexed keywords

ARTICLE; CDKN2A GENE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FHIT GENE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MERKEL CELL TUMOR; POLYOMA VIRUS; PRIORITY JOURNAL; PROMOTER REGION; PTPRG GENE; RASSF1A GENE; TP73 GENE; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION; GENETICS; ISOLATION AND PURIFICATION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SIMIAN VIRUS 40; SKIN TUMOR; VIROLOGY; VIRUS INFECTION;

POLYOMAVIRUS;

ACID ANHYDRIDE HYDROLASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA BINDING PROTEIN; FRAGILE HISTIDINE TRIAD PROTEIN; NUCLEAR PROTEIN; PTPRG PROTEIN, HUMAN; RASSF1 PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73; VIRUS DNA;

ACID ANHYDRIDE HYDROLASES; CARCINOMA, MERKEL CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, VIRAL; DNA-BINDING PROTEINS; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; PROMOTER REGIONS, GENETIC; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; RETROSPECTIVE STUDIES; SIMIAN VIRUS 40; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 70349971704     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20540     Document Type: Article

References (32)

1. Lemos B, Nghiem P. Merkel cell carcinoma: More deaths but still no pathway to blame. J Invest Dermatol 2007;127: 2100-2103. (Pubitemid 47258499)
2. Becker JC, Houben R, Ugurel S, Trefzer U, Pfohler C, Schrama D. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol 2009; 129:248-250.
3. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-1100. (Pubitemid 351300792)
4. Garneski KM, Warcola AH, Feng Q, Kiviat NB, Leonard JH, Nghiem P. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol 2009;129:246-248.
5. Shuda M, Feng H, Kwun HJ, et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 2008;105:16272-16277.
6. zur Hausen H. Novel human polyomaviruses-Re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 2008;123:247-250.
7. Kassem A, Schopflin A, Diaz C, et al. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 2008;68:5009-5013.
8. Houben R, Michel B, Vetter-Kauczok CS, et al. Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma. J Invest Dermatol 2006;126:1135-1142.
9. Van Gele M, Speleman F, Vandesompele J, Van Roy N, Leonard JH. Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridization. Cancer Res 1998;58:1503-1508. (Pubitemid 28193615)
10. Lassacher A, Heitzer E, Kerl H, Wolf P. p14ARF hypermethylation is common but INK4a-ARF locus or p53 mutations are rare in Merkel cell carcinoma. J Invest Dermatol 2008;128:1788-1796. (Pubitemid 351847382)
11. Van Gele M, Kaghad M, Leonard JH, et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer 2000;82:823-826. (Pubitemid 30085233)
12. Leonard JH, Williams G, Walters MK, Nancarrow DJ, Rabbitts PH. Deletion mapping of the short arm of chromosome 3 in Merkel cell carcinoma. Genes Chromosomes Cancer 1996; 15:102-107. (Pubitemid 26048410)
13. Popp S, Waltering S, Herbst C, Moll I, Boukamp P. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 2002;99:352-360. (Pubitemid 34495849)
14. Sozzi G, Alder H, Tornielli S, et al. Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res 1996;56:2472-2474. (Pubitemid 26170675)
15. Foja S, Goldberg M, Schagdarsurengin U, Dammann R, Tannapfel A, Ballhausen WG. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas. Liver Int 2005;25:1202-1208. (Pubitemid 41782566)
16. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-428.
17. Van Gele M, Boyle GM, Cook AL, et al. Gene-expression profiling reveals distinct expression patterns for classic versus variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small-cell lung carcinoma. Oncogene 2004;23:2732-2742. (Pubitemid 38586327)
18. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000;25:315-319. (Pubitemid 30437320)
19. Rastetter M, Schagdarsurengin U, Lahtz C, et al. Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma. Histol Histopathol 2007;22:1005-1015. (Pubitemid 47034166)
20. Spugnardi M, Tommasi S, Dammann R, Pfeifer GP, Hoon DS. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Cancer Res 2003;63:1639-1643. (Pubitemid 36373656)
21. Dammann R, Takahashi T, Pfeifer GP. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene 2001;20:3563-3567. (Pubitemid 32619409)
22. Hosoe S, Shigedo Y, Ueno K, et al. Detailed deletion mapping of the short arm of chromosome 3 in small cell and non-small cell carcinoma of the lung. Lung Cancer 1994;10:297-305. (Pubitemid 24115520)
23. Hachana M, Trimeche M, Ziadi S, Amara K, Korbi S. Evidence for a role of the Simian Virus 40 in human breast carcinomas. Breast Cancer Res Treat 2009;113:43-58.
24. Liu L, Zhang J, Bates S, et al. A methylation profile of in vitro immortalized human cell lines. Int J Oncol 2005;26:275-285.
25. Toyooka S, Pass HI, Shivapurkar N, et al. Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. Cancer Res 2001;61:5727-5730. (Pubitemid 32769086)
26. Li HP, Leu YW, Chang YS. Epigenetic changes in virusassociated human cancers. Cell Res 2005;15:262-271.
27. Furuta J, Nobeyama Y, Umebayashi Y, Otsuka F, Kikuchi K, Ushijima T. Silencing of peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res 2006;66: 6080-6086.
28. van Doorn R, Zoutman WH, Dijkman R, et al. Epigenetic profiling of cutaneous T-cell lymphoma: Promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol 2005;23:3886-3896. (Pubitemid 46218691)
29. Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Cancer Res 2002;62:3698-3701. (Pubitemid 34728849)
30. Xiong Z, Laird PW. COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:2532-2534. (Pubitemid 27303718)
31. Agathanggelou A, Cooper WN, Latif F. Role of the Rasassociation domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005;65:3497-3508. (Pubitemid 40616319)
32. Dammann R, Schagdarsurengin U, Seidel C, et al. The tumor suppressor RASSF1A in human carcinogenesis: An update. Histol Histopathol 2005;20:645-663. (Pubitemid 40468282)